♪ carol: i'm carol massar in boston in for emily chang. this is the "best of bloomberg: technology." coming up, we highlight our coverage from boston, including the innovations and industries that are driving the city. we've got guests leading the way in biotech, academia, and sports. plus, we sit down with a guest, getting his thoughts on the trade war, volatility, and the

future of professional sports. and turbulence and turnover at ge has upended the plans for the city of boston. we find out exactly what happened. boston is a city famous for igniting a revolution and is once again leading the way. the bloomberg innovation survey finds massachusetts as the second most innovative place for business in the country. and boston is a primary driver of that destination. from venture capital funding to academic brainpower, boston is undergoing a revolution into its economic future. boston, a city that knows a thing or two about revolution is -- revolution, is undergoing a new one, an innovation revolution. boston tech is booming, powering massachusetts to the second highest spot in the nation on bloomberg's state innovation index, based on factors including the region's research and development and education

levels, and its number of tech companies. >> the score is really high, and much of that was led by the boston area, which is a tech hub. it has many programs for science and engineering and also has a high tech company density, as well as robust venture-capital investment. carol: on tech density alone, the bloomberg index ranked the state number one. more than 60% of all publicly traded companies are classified as high tech. >> one of the main reasons it's ranked so high is because of the tech company density. and a lot of that is led by the boston region. if you think of some of the top s&p 500 companies, be it biogen, raytheon, some of them are in massachusetts, some in boston. carol: that tech density is no accident, given the boston brain burst of including 70 graduate programs. in an area where 47% of adults

have college degrees, 40% are in science or engineering. there are now 1.3 million jobs in the innovation economy, an 8.6% jump since 2012. a beantown boost in capital investment has helped fuel that job growth. in 2018, vc firms invested $7.6 billion in boston area companies, an increase of 126% in six years. amazon's $800 million purchase this online pharmacy was a coming out party for the area's startup sector, and a shot heard around the country in boston's new innovation revolution. carol: all week long, we've been highlighting the innovation taking place in the city. in august of last year, it saw total venture investments exceed rivals with $5.2 billion raised. now, one example is toast, a

leading all in one point-of-sale restaurant management platform. and the company just raised millions last month, ringing the -- bringing the valuation to a whopping $2.7 billion we caught up with the ceo. >> we'll do a lot with the money. it's a nice capital raise. we've been busy over the last two years. we're really trying to affect a lot of change across the restaurant community. and we're enabling what we call a new era of hospitality. carol: so, talk to me about the r&d. you've got a platform, services. what else do you want to do with it? >> we look at the stakeholders, the guests, the employee, and the owner and operator. we're trying to affect change across the whole spectrum. a big example is how do you get orders to the restaurant? in today's consumer environment, how does the restaurant get orders in? whether it's a tool like toast

takeout, which allows you to do mobile orders ahead, or if it's kiosk, or online ordering, or a device called the toast go, that allows the wait staff to take orders at the table and turn tables faster. carol: this is what it's about, more customers in, more tables means more revenue and more tips for the workers. >> i'd say it's two things, more revenue in the store and operational efficiency. carol: you started back in 2011. where is it all going? you've been around eight or nine years. you've got to be thinking, is this is the time to take the company public? >> yeah, so, this is a massive opportunity and the restaurant community is a massive market. carol: untapped market? >> untapped market, yeah, and we're in the days of a massive transformation. carol: so you don't feel the pressure to do that? >> no pressure. carol: the reason i guess i ask

is because we've been focused on a couple of stories. more important and maybe pertinent to you is some of the ipo's that have come to market. these are companies that have been around for a decade, like uber. it didn't go so well, and i'm wondering if you think about how long you stay private. >> first, we're happy being private and put investment to pilots in our and the breakthrough for the future. i've had a lot of friends who have gone public recently and we're in no rush. we're after building long-term shareholder value, so when we look at the opportunity for us, it's to build a pillar company for the restaurant community that builds long-term investor value. carol: as you say, it was a very untapped market. i know you don't like to give up numbers, but give me an idea of the growth rate and terms of bringing in new customers. >> we're north of 100% year-over-year. carol: in terms of the customer

base? or revenue? >> both. carol: wow. >> and we have 1500 employees. since we last met, we've added 1000 in the past couple of years. carol: and not just in the u.s. >> we have an engineering center in dublin, but we're still in u.s.-based. we serve restaurants across the u.s., whether it's an enterprise like a jamba juice or nationally acclaimed restaurants. we're all over the u.s. of a, but it's still the early days. carol: putting going public partnerships, what about other sides? where else can you go or where else do you hope to go? >> sure, so we look at the entire restaurant value chain and we're trying to make their lives better. this week, we announced toast payroll and team management. because a lot of operators are spending hours doing payroll every friday. if we can give them their fridays back and streamline payroll so that they can get

hours back on efficiency to spend more time with guests, that's what we're doing. we launch that this week, which is an exciting new venture and we will continue to innovate. carol: back office, front office, whatever it is. >> whatever it is. carol: there's a lot out there, a lot of competitors even in the boston area. there's something about the city , the tech scene, the innovation seen, the restaurant space, there's a lot happening. how do you see the competition? is it folks you might partner up with? i don't know. how do you see it? >> there are areas where we build, areas where we partner. it's a space that's dynamically changing. at the end of the day, we want to help transform the community and move the community forward. and the boston market is tremendous. it's sort of two sides of the market. you've got this amazing supply chain of talents with m.i.t., bu, umass, harvard, plenty of talent.

and then you've got, on the other side of the market, these companies that are transforming industries like wayfarer, car gurus, toast. it's an amazing market for us to thrive in and an awesome restaurant community. carol: you mentioned what a great city to be in an terms of talent. what about in terms of what you guys are doing? about replacing workers? how do you see that working? >> we feel we're enabling the community to thrive. a lot of restaurants running toast are adding workforce. they can spend more time with guests, more time cooking, more time managing the operations. so, we see a lot of restaurants thriving and adding labor and we're trying to make it easier. carol: just 10 seconds, international expansion? is that in the works, too? >> at some point, not anytime soon, but at some point. carol: that was the toast ceo.

coming up, moderna was the biggest tech ipo ever, but they have faced pressure from the public. we talk to the ceo about moving into the markets and staying on the cutting edge. and if you like bloomberg news, do check us out on the radio. you can listen to us on the bloomberg app and in the united states on sirius xm. this is bloomberg. ♪

carol: this is the "best of bloomberg: technology" in boston this week. i'm carol massar. boston is arguably the center of the biotech world, but amongst this competition, moderna stands out.

it's based in cambridge, and the company's focused on creating therapies from infections to cardiovascular diseases. they went public last year in what turned out to be the biggest biotech ipo ever. i caught up with the ceo to talk about what's changed since the ipo. >> i think the big difference for us and our employees is we used to share data all the time, all the time with everybody. to do great, you need to do science and to do science, you need people understanding all the pieces. so that's the biggest change. carol: so you're sharing more data? >> we're sharing less data -- --ol: less data >> because now we have to be careful. carol: because you're publicly held. that's interesting. what's changed in terms of the work you're doing and the

perception with your partners? >> mostly the same. our first partnership with astrazeneca goes back to 2013. we have a lot of long-term investors like fidelity, long-term investors for a long time. it's the same for us. carol: i guess what i wonder is, there's something different, right, between being privately held and becoming public? you have to answer to investors. i think there's been a lot of talk about your valuation out of the gate, over $7 billion. i'm just curious, what kind of questions, are you getting from investors? things take a while, but you're public now. >> again, because we had, for many years, we've quality investors, the story has been the same. we have a technology that will build a new kind of medicine. we're building medicines and that cannot be done with small molecule or biotech products. what's very unique is that it's

information molecule. every time we inject into a human, and we've done it a thousand times with a thousand different subjects, locations we've done it already. every time we inject a human, we give them an instruction for their own cells to make the medicine. and because of that, we have a platform. and because the human genome has been sequenced now, we know all the instructions for all of the proteins we have. we can take that information into our technology and very quickly give instruction to your body of making protein you need to be healthy. carol: you say very quickly, how quickly is it proceeding? because any kind of pharmaceutical, if you will, as you know better than most, it takes several procedures in terms of critical testing. i think about the valuation. and at some point, investors are going to say are we in stage three?

where are we in the process? >> you've got to think about two things. one is research, to understand the drop before it's ready to go into clinical trial. so in the labs, we're able to move very, very fast because the human genome has been sequenced. and because the technology is always the same, we don't have two invent the product is the same every time. the only difference is the message, like zeros and ones on the software. carol: so, same process for going after the protein. >> correct. if you look at 20 different drugs in development, many more areesearch, all of them made using a similar manufacturing process. it's not like it used to be where with every drug, you've to reinvent the process. so we can go very, very fast. carol: can you make the assumption in the efficacy is going to be the same in every process? even if the process is in terms of how you deal with an

individual's body. but can we assume the efficacy is going to be the same? >> so, it's tough to say ahead of seeing the data, but the thing that's interesting is, because you make your own protein, and it's a protein known to your body -- carol: tight, like a custom medication. >> right. it's been around for millions of years. when you think of drugs like prozac, those are being invented. when we inject instruction in your body, it's to make a protein that you're already making that is natural in humans. carol: so you know, and this is not going to come as a new argument you, it's kind of the holy grail, right? the idea of using the body to create a treatment, a pharmaceutical pharmaceutical, if you will, or not really. a treatment to deal with some

disease or element. what makes you think you've the magic stuff to make it work this time? >> i think we are resting on the shoulders of giants. a lot of the technology we're using has been invented by others of the last 20-40 years. just one example, we use next gen sequencing. so we use machines to sequence the human genome. these we did not invent. we are using those machines that are getting us information that we can then use to go into the technology. so, there is a lot of technology that comes together to make moderna possible. i'd like to say that 10 or 15 years ago, we could not have existed. carol: that was the ceo joining us. well, coming up, where it went wrong for general electric. how the company's move to boston didn't come out as planned. that's coming up next. this is bloomberg. ♪

carol: welcome back to "best of bloomberg: technology" in boston. i'm carol massar. it was supposed to be ge's crowning moment, that the company decided to move its headquarters to boston with its promise of infrastructure and jobs in exchange for tax relief and incentives. somewhere down the line, it all went wrong. here's how it went down. for 40 years, ge called fairfield, connecticut home. that changed in 2016, announcing they were moving its headquarters to boston. >> the ceo at the time was really trying to reinvent the company as a digital industrial company. they wanted a software focus, to be closer to engineers, and boston really was a good fit. carol: boston and ge looked like perfect partners. ge would build a new corporate headquarters and bring 800 new jobs to the city.

boston pledged $25 million in property tax relief and the state of massachusetts kicked in $120 million in additional incentives. boston mayor marty walsh was exuberant about the deal. carol: millions of incentives, how do you know it's worth it? >> i think it's already worth it. ge is moving to the city of boston. we have other great companies, as well, but general electric is one of those that's such a big win for the city. carol: years later, the good feeling was still flowing at the groundbreaking ceremony. >> i think boston should look to the future with great promise and great optimism. >> this is the start of what i would like to call a terrific relationship. carol: by the summer of 2017, though, the ground had shifted for ge. >> started to see cracks in ge's financials. so their cash flow was a huge disappointment.

their organic sales growth didn't materialize as promised. when it he was made ceo, i don't think anybody realized quite how bad things were for ge. carol: in august 2017, the company announced it would delay construction of its new tower, pushing completion back two years to 2021. as the stock price plunged, the slipped far down his successor's list of priorities. >> the problem was he was too grand, too ambitious. he wanted a ge to be the be-all, end-all of all things software. as these cash problems mounted, it became apparent that this digital effort was too ambitious. that's why you started to see he and his successor walk down this ambition. >> we have a lot of work to do. we need to strengthen the balance sheet and set the business of to win. carol: in february of 2019, ge

abandoned its plan to build a new headquarters and announced that only 250 new jobs would come to boston. the company won't be seeking property tax relief and reimbursed of the state of massachusetts for $87 million in expenses. ge will remain in boston as a renter, after reaching a deal to sell the land to a real estate development group. >> definitely something that needed to happen and i think they're going about it in the appropriate way. not just from a cash standpoint, but from a pr standpoint. they're clearly trying to say that we like boston, want to be here, but we just don't have the capacity that we did when we started this process. carol: to weigh in on what happened at ge, we caught up the ceo of wasabi. the company is taking on the likes of amazon. we begin on the challenges of facing international and industrial companies, such as ge

, in an increasingly digital world. >> when you look at the giants of the technology space, amazon, google, facebook and so forth, they really started in this new, digital way. and it's hard for industrial companies that are used to doing things in a certain way, everything from technology to accounting, it's entirely different and the culture is different. so i think it's very hard to do. and quite honestly, i think people still need manufactured products. and i'm not sure that it's a good idea for people making good to pivot. carol: really who you are. >> still got to manufacture. carol: that's a good point. there are a lot of goods that need to be manufactured. >> they need to do a lot to be successful. carol: that was the ceo of wasabi.

coming up, we hear from the co-owner of boston's beloved celtics. that's coming up next. and this is bloomberg. ♪

carol: welcome back to "best of bloomberg technology" this week in boston. i'm carol massar at the rose kennedy greenway. this week, rising trade tensions between the u.s. and china had market watchers on edge. on tuesday, we caught up with a guest who is no stranger to market volatility. he's the cochairman of one of the leading investment firms. he's also the co-owner of boston's legendary nba team, the celtics. >> well, this has been a long time coming. we've had a trade imbalance for 30 years. initially, when you had emerging markets, it was a good thing.

and it's lifted the whole global economy up. i think over a billion people have come out of poverty because of global trade. businesses have prospered. these markets aren't emerging anymore. it's time to rebalance. it's a more fair system. that's what's happening now. carol: you have investments in china. >> i do. carol: i'm curious, basically saying china is not our friend. how do you see the chinese market in terms of transparency issues and where they are positioning themselves against the rest of the world? we've had a lot of success in a chinese markets. they crossed over to a service economy for many years, driven by exports and manufacturing. we haven't been that affected and won't be that affected by the trade issues. so, i think it's more of a global issue. if you think about it, 500 million goods come in from china to the u.s. and 100 billion go -- goes out, so that's a large

imbalance. obviously, there should be rebalancing. if we get into a long-term trade war, we need to rebalance in terms of them taking our goods, having similar things on patents, protection of software. carol: do you think we can get that, in terms of enforcement? steve: they've come a long way since the early days, and the service companies can take control positions in china. i think they realized to be on the global stage, they have to have the same kind of rules as western economies, and we have to negotiate something to come to the middle. it's too important not to get that done. carol: president xi and president trump like to win, and are thinking about their constituencies back home. is that going to be problematic in terms of getting a deal done?

steve: i think they're both strong dealmakers and strong leaders, and they'll recognize it's bad for each country to be in this situation. so i'm hoping that cooler minds will prevail. they are good leaders and are trying to get something good done. carol: all the market volatility we see, the you which of you that the china trade negotiations, or is there something fundamentally going on in our market economy right now? steve: there's more going on, the good news is record low unemployment. that really puts the u.s. in a strong position. not much inflation, as well. so, i think it's a strong negotiating position. the markets are probably as high as they've been, we have had an 11 year expansion. there will probably be some correction or settling. right now, the economies are doing pretty well.

carol: in terms of the companies under the bane empire, in terms of trade, has that impacted them to do anything differently? steve: all of the companies have contingency plans in terms of supply chain. most of corporate america has gotten ahead of this because it's been going on for a couple years. as soon as this started to go on, our companies developed action plans. how do you make it work, economically? they are prepared to switch, and many have diversified in terms of the supply chain. many countries decide china have been involved in the global supply chain, and companies have the flexibility to shift supplies. the companies are very quick and nimble. so they will get through this. i would rather not have the trade war. i would rather have it settled. carol: one thing we've been captured by is the uber ipo. a lot of stories about what markets get wrong in terms of bringing this to market.

did morgan stanley overvalue the company? how do you see that? out atwe actually came the low end of the range. i don't know if i blame morgan stanley. i think it was a well done offering. but we have volatility with trade. we have a market that's volatile in general, at an all-time high. anything to do with trade or political tensions affects the market in the short-term. when google went public, it took a beating and went way down. there will be some volatility in these tech offerings. they got hit at a choppy time in the market. carol: i'm also curious about the private equity environment and how you see it. we talk about dry powder. what do you think about valuations? steve: no question valuations are high.

but i believe -- i thought they were all true all those times, but bain capital has grown from 36 million in 1984 to 205 billion today and have had successful returns. why? it's because private equity really is a great business model. it really tries to come in and tries to transform businesses, and the model has proven to go global, help merge acquisitions, companies get more efficient. the whole world has changed in terms of private equity and the value added by bain capital, which is founded on the principle of consulting skills and bringing those to companies to create great businesses. carol: what are the kind of deals you are looking at right now? or what areas are you looking at now that you find interesting? steve: we find it as a needle in a haystack. you need to proceed with caution

in these markets. we have a global team of a thousand people looking at thousands of deals, and we cover the waterfront. in the last 10 years, we've become specialists and we've had a big technology practice. we've reorganized to have vertical markets, which include technology, health care, consumer retail, industrial, and financial services. we work together as a global team to look at those opportunities. you've got to start with hundreds and thousands of opportunities and we'd them down. carol: you created a real estate unit last year. you want to raise a billion dollars, if you hit that mark? steve: absolutely. it was a fantastic situation. there was a fantastic group, they really fit with bain capital, only three miles from us. and the team came over, we had office space and they became bain capital. it was a seamless transition. they have focused on great

growth segments in real estate, such as medical offices, college dorm facilities, biotech, which is booming. they're very successful and we're proud to have been part of the bain capital family. carol: i have to ask you about sports or people would yell at me. >> sure. carol: i'm sorry you were done for the season. what did you learn this season? steve: you always learn is hard to have that playoff game and not come back. we had a great coach. the credit goes to milwaukee, who could win the entire nba. the future is bright for us, we will have up to four first round draft picks. the future is bright for our team.

this time, the ball didn't bounce our way. i watched the end of the toronto-philadelphia game, a long shot way out as time expired. i had visions to my high school days of that happening to me watching that ball go in, and your season is over. it's terrible. carol: will mr. irving be back with the team? steve: we can't talk about that, but adam silver is strict on these issues. carol: that was steve pagliuca, cochairman of bain capital and co-owner of the boston celtics. coming up, we see reebok headquarters. this is bloomberg. ♪

carol: welcome back to "best of bloomberg technology." i'm carol massar. we spent some time with reebok, which is in the midst of a

turnaround. a decade ago, adidas bought the sneaker company for $4 billion. revenue dropped 3% in 2018 causing the company to cut costs more. reebok is looking to expand. we caught up with the vice president. >> we are in the fortunate situation. we have a very diversified strategy. carol: and you've been doing that for a while. >> this makes us less dependent on the portion we're producing in china. carol: not so much of an issue. >> not so much of an issue. carol: having said that, china is an important market, and i'm curious as you innovate new products, i remember your sneakers so well in college. but you've made a commitment to being about 100% fitness. and you've seen dramatic growth in apparel. tell me about that. >> well, the fitness industry is

not just about footwear, luckily for me. power plays an important role, and innovative products. one product we launched last year in august and we, throughout our research and talking to women, realized there despite theoblem, fact there are bras out there. they're either feeling pain when working out or not feeling comfortable, so they don't work out at all. we created the first innovative bra that combines a second skin feeling with the support you need while working out. carol: you brought over a bottle of sick, clear solution. that's really the chemical or compound that makes up this bra. barbara: yes, correct, it is when you press it softly, it's fluid and elastic. when you approach it with force. -- but when you approach it with

force, it actually stiffens. carol: how much, in terms of apparel, not just about design, but it's more about technology, different fabrics, really exploring that to create new products? barbara: i'm in the industry for 25 years, and over the last 10 years, there's been a gigantic leap in the innovations in apparel. a lot of it is because of the manufacturing abilities we have today, but also the innovations we're seeing on the fabric side. our job is to find out what the consumer wants, so everything starts with the consumer, and then we need to bring it back and find new ways, address it by creating new suppliers, or going outside the industry to find a solution. carol: does that mean you're working with a lot of chemical companies or companies that are creating new materials? when i started working out, it

was similar or the same stretchy fabric. i do wonder, what is the future of fitness apparel? barbara: it's going more diversified. yes, working with chemical companies, but also working with the mills that create those fabrics in order to create the right components, the right ingredients that solve the problem. then i would say today, more than ever, it will be more in the future, about finding those smart fabrics that allow you to personalize your garments to your activity, to your body. carol: in terms of the apparel industry, there are a lot of competitors out there, but you've grown that side of the business over the past four years by double digits. do you continue to see that growth? barbara: yes, we continue to see that growth, but there is a lot of competition and opportunities

out there. the fitness industry, and the wellness trend will be there to stay. consumers are not only looking for products they can work out in. they are also looking for product they can wear the other 10 hours of the day while they are out with their children on the playground, or commuting to work. carol: we started talking about china, and you had your first fashion show in shanghai. you created a creation center in shanghai last year. it's an important market to you. when you're either selling to china or other markets, are you designing specifically for that customer? barbara: so, we are looking very closely into the regional needs, and it may be as simple as reading products and making sure we have asian or japanese sizing available, but we're also looking, specifically, for big markets like china and what the product needs specifically for these markets.

that's why we opened our creation center there and we're working closely with the shanghai center so that we're maximizing innovations and products we're developing here. carol: reebok's barbara ebersberger. coming up, robot recyclers. how m.i.t. is using robots for recycling to keep the planet clean. that's next. this is bloomberg. ♪

carol: welcome back to "best of bloomberg technology." i'm carol massar in boston. before last year, china imported about 40% of u.s. recycles, the -- u.s. recyclables. ban recently researchers are estimating 111 million metric tons of plastic will be left with nowhere to go. students at m.i.t. have

developed a robot that can identify and sort recyclables. it's dubbed growth cycles. for more than three decades, china has been one of the biggest importers of plastic waste. that's changing. last year, china closed its doors to over two dozen foreign recyclables, sending countries scrambling to fix their system. before the ban, china imported about 40% of the united states recyclables. and researchers estimate the new policy could leave 111 million metric tons of used plastic with nowhere to go. now, a team of researchers at m.i.t. is looking to sort through the pileup. due to their learning lab, they developed a robot that can actually identify and sort the recyclables. the system includes a soft teflon hand that uses tactile sensors to detect the size of an object and the pressure needed

to graft it. from there, it determines if it's made of metal, paper, or plastic and create a pass. as it stands, recycling centers, materials can become recyclable altogether. approximately 25% of all u.s. recyclables are so contaminated, they must be sent to landfills instead. the team says rocycle can tackle the problems of today's a single stream recycling system. rocycle also provides a safe alternative to human labor. it can be cultured by a needle 20 times with minimal damage. one complication, replicating human intuition is no easy feat. while rocycle can detect materials 85% of the time, but its success rate drops 20% when objects are put on a moving conveyor belt. meanwhile, other companies are building their own sorting robots, using cameras and computer vision, and estimate the technology can cut recycling

costs by as much as 50%. reducing contamination is a top priority for the united states. could a robot such as rocycle be a step in the right direction, or will america have to find a new dumping ground? and we caught up with the director of the m.i.t. research lab that created the recycling robot. >> just think about the fact that 20 years ago, this was a task reserved for experts. today, we depend on computing so much we don't even know how we depend on it. and the next level of technologies, the ai machine learning technologies, will do so much more for us. carol: how? we've been hearing that for a while. >> let me give you examples from rocycle. imagine garbage bins that will take themselves out.

imagine an automated infrastructure that will take garbage away. rocycle and able the correct sorting of all that garbage so that it's environmentally good. imagine fresh produce that shows up on your doorstep's, delivered by drones. imagine intelligent systems that ensure you optimize your life to live well and to work effectively. imagine transportation systems with no accidents. imagine personalized treatment plants. imagine all these possibilities that remove the routine work from us and ensure that we have time to think critically, to think creatively. carol: what do you say to people who say this means the replacement of so many jobs out there? is that where we're going, or is

it more a case of robotics working side-by-side with humans? daniela: i hear a lot of inside -- anxiety and concerns about ai. i have worked in the field for many years and i want to ensure everyone the concerns around opocalypse are greatly exaggerated. but we have to understand the fears of those who are not sure what the technology can do. and to start understanding that it's important to provide people with alternative viewpoints. part of this is understanding of robotics and ai are tools. they are just tools created by people for the people. like any other tools, they are not inherently good or bad. we can choose to do so many things, like removing road accidents, offering personalized medicine, ensuring that people can communicate no matter what language they speak.

carol: we've started to see a trickle of the impact of ai and robotics on our society, but how soon before we feel a bigger impact? daniela: we already have a tremendous impact because with ai technologies, medicines are getting more precise and personalized. we can see the potential of optimized transportation systems that deliver goods and people much more efficiently. and in the future, we will see so much more. carol: you guys work with so many well-known companies, the milieu to the audience, toyota, google, ibm, they have opened up major facilities in cambridge in the past few years. talk about the collaboration between academia and the private world. daniela: it's really critical that academia and the private world get together to solve some of the world's greatest challenges. by working with companies we understand where the pain points are, and we can direct the

signs to learn where those pain points are. we can show companies what is coming around the corner, what the technologies that disrupt are coming. carol: it's interesting you say that because i think about self driving cars, and if you go back five years it was not until tesla came on the scene that people took it seriously. they really pushed everybody to move forward. what technologies that we're not talking about much will be a big deal around the corner? daniela: well, around the corner, we'll see a whole different category of robots. today, most of the robots we see are inspired by the human face, they have arms, or are on wheels. in the future, we will see robots that work side-by-side with humans. robots are made of soft materials, robots made of a variety of materials, whether paper or silicon or plastic. more variety of machines, and more variety in the scope of the machines.

carol: so what are you doing, as i'm walking around here saying seeing students work in groups, what are you doing to prepare students for what is needed for the future and robotics? daniela: we're offering a wide range of important classes. machine learning is very popular these days. last year, over 700 students of -- took machine learning. we're offering free classes online and creating new disciplines and academic degrees that enable students in technology and something else. for example, we just launched a degree in competition urban science, where we're training students in technology and policy. carol: that was daniela rus. that will do it for this edition of "best of bloomberg technology." from the rose kennedy greenway in boston. and remember, bloomberg technology is live streaming on

twitter. check us out @technology, and on tictoc on twitter. this is bloomberg. ♪

alix: the trade war reignites. lng and soybeans are driving deeper into the battle between u.s. and china as china raises tariffs on key commodities. driving into the future, electric buses and cars will take over the world faster than you think with china leading the way. the hotspots for oil. tensions flare in the persian gulf. saudi arabia confronts trouble in the straight of hormuz and a key pipeline. where is the risk for oil? ♪ alix: welcome to bloomberg "commodities edge." 30 minutes focused on the companies, physical assets